BAL PHARMA Fact Sheet, BAL PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA Fact Sheet    (BPHR)


Revealing on July 30th: Asset Class Outlook and Economic View Post Covid 19


Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

BAL PHARMA Price History

Price Rs 94.6
Mkt Cap Rs m 1,402
Vol '000 3.2
P/E X -39.5
P/CF X -26.9
EPS (TTM) Rs -2.4
% ch % -2.2
No. of shares m 14.82
% ch week % -7.8
% ch 1-mth % -3.9
% ch 12-mth % 130.7
52 week H/L Rs 138.0/39.0
(As on Jul 28, 2021 12:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAL PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BAL PHARMA EQUITY SHARE DATA
High Rs16812312810979 
Low Rs5081756324 
Sales per share (Unadj.) Rs150.9157.3146.2158.8120.7 
Earnings per share (Unadj.) Rs0.2-0.30.31.5-9.1 
Diluted earnings per shareRs0.2-0.30.31.5-8.7 
Cash flow per share (Unadj.) Rs5.64.35.05.9-3.7 
Dividends per share (Unadj.) Rs1.001.001.001.000 
Adj. dividends per shareRs0.870.960.960.960.00 
Dividend yield (eoy) %0.91.01.01.20 
Book value per share (Unadj.) Rs41.144.145.947.037.0 
Adj. book value per shareRs35.742.143.845.035.4 
Shares outstanding (eoy) m12.8714.1714.1714.1714.17 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.70.60.70.50.4 
Avg P/E ratio x540.4-365.1382.556.5-5.6 
P/CF ratio (eoy) x19.323.820.214.6-13.9 
Price / Book Value ratio x2.72.32.21.81.4 
Dividend payout %497.0-357.9376.965.80 
Avg Mkt Cap Rs m1,4021,4481,4401,217727 
No. of employees `000NANANANANA 
Total wages/salary Rs m373454522503504 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BAL PHARMA INCOME DATA
Net Sales Rs m1,9412,2292,0712,2501,711 
Other income Rs m1330171018 
Total revenues Rs m1,9542,2592,0882,2601,729 
Gross profit Rs m14914817317750 
Depreciation Rs m7065686277 
Interest Rs m658594127127 
Profit before tax Rs m262929-2-135 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m243325-24-6 
Profit after tax Rs m3-4422-129 
Gross profit margin %7.76.68.47.92.9 
Effective tax rate %90.2113.886.91,166.04.7 
Net profit margin %0.1-0.20.21.0-7.5 
BAL PHARMA BALANCE SHEET DATA
Current assets Rs m1,4301,6461,8481,8301,611 
Current liabilities Rs m1,1121,4321,5441,6321,595 
Net working cap to sales %16.49.614.78.81.0 
Current ratio x1.31.11.21.11.0 
Inventory Days Days1512777 
Debtors Days Days107101113105106 
Net fixed assets Rs m680688754783773 
Share capital Rs m129142142142142 
"Free" reserves Rs m400483508525383 
Net worth Rs m529624650666524 
Long term debt Rs m350178347288231 
Total assets Rs m2,1102,3332,6022,6132,384 
Interest coverage x1.41.31.31.0-0.1 
Debt to equity ratio x0.70.30.50.40.4 
Sales to assets ratio x0.91.00.80.90.7 
Return on assets %3.23.53.85.7-0.1 
Return on equity %0.5-0.60.63.2-24.6 
Return on capital %10.414.212.313.1-1.1 
Exports to sales %56.451.847.756.260.5 
Imports to sales %25.026.119.916.115.6 
Exports (fob) Rs m1,0941,1549871,2661,035 
Imports (cif) Rs m486582412362266 
Fx inflow Rs m1,0941,1549871,2661,035 
Fx outflow Rs m502605432390291 
Net fx Rs m592550556875743 
BAL PHARMA CASH FLOW
From Operations Rs m -194 63 6 78 231 
From Investments Rs m -139 -80 -36 -80 -47 
From Financial Activity Rs m 324 -59 35 0 -200 
Net Cashflow Rs m -9 -76 5 -3 -16 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 4.4%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 55.2%
Shareholders 16,531
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 21 & 22, Bommasandra Industrial Area, Hosur Road, Bengaluru - 560099
E-MAIL -- WEB www.balpharma.com
TEL +91-080- 27833156 FAX +91-080- 27835482
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT TSR Darashaw Consultants Pvt Ltd., C-101 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli West
YEAR OF INC: 1987 BSE CODE: 524824 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   PARMAX PHARMA  METROPOLIS HEALTHCARE  HEALTHCARE GLOBAL ENTER.  SCANDENT IMAGING  MERCURY LAB.  

Compare BAL PHARMA With:   PARMAX PHARMA  METROPOLIS HEALTHCARE  HEALTHCARE GLOBAL ENTER.  SCANDENT IMAGING  MERCURY LAB.  




Today's Market

Sensex Corrects Over 700 Points; Banking and Pharma Stocks Under Pressure(11:30 am)

Share markets in India have extended early losses and are presently trading deep in the red. Weak global cues dampened investor sentiment.

Views on news

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

India's Vulture Moment Against China (Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

Top 5 Stocks Mutual Funds Bought and Sold in June 2021 (Views On News)

Jul 15, 2021

A look at what India's top equity mutual funds bought and sold in June 2021.

Zomato: Worth a Bite? (Profit Hunter)

Jul 15, 2021

Zomato has been a consumer's delight. Can it be an investor's delight too?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BAL PHARMA

  • Track your investment in BAL PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BAL PHARMA

BAL PHARMA 8-QTR ANALYSIS

COMPARE BAL PHARMA WITH

MARKET STATS